ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| Weiss Ratings | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.07 | |||
| Price History | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.48% | |||
| 30-Day Total Return | -15.10% | |||
| 60-Day Total Return | -40.14% | |||
| 90-Day Total Return | -81.95% | |||
| Year to Date Total Return | -52.73% | |||
| 1-Year Total Return | -91.19% | |||
| 2-Year Total Return | -94.26% | |||
| 3-Year Total Return | -96.89% | |||
| 5-Year Total Return | -90.38% | |||
| 52-Week High % Change | -94.55% | |||
| 52-Week Low % Change | 87.01% | |||
| Price | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.48 | |||
| 52-Week Low Price | $0.22 | |||
| 52-Week Low Price (Date) | Feb 03, 2025 | |||
| 52-Week High Price (Date) | Apr 16, 2024 | |||
| Valuation | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.73M | |||
| Enterprise Value | 38.82M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.52 | |||
| Earnings Per Share Growth | 144.92% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.61 | |||
| Price/Book (Q) | 0.20 | |||
| Enterprise Value/Revenue (TTM) | 3.04 | |||
| Price | $0.42 | |||
| Enterprise Value/EBITDA (TTM) | -1.39 | |||
| Enterprise Value/EBIT | -1.10 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.08M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.30 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.30 | |||
| Company Info | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 215 345 0919 | |||
| Address | 711 Stewart Avenue Garden City, NY 11530 | |||
| Website | www.prophaselabs.com | |||
| Country | United States | |||
| Year Founded | 1989 | |||
| Profitability | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -277.69% | |||
| Profit Margin | -217.64% | |||
| Management Effectiveness | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -24.12% | |||
| Return on Equity | -- | |||
| Income Statement | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 12.75M | |||
| Total Revenue (TTM) | 12.75M | |||
| Revenue Per Share | $0.67 | |||
| Gross Profit (TTM) | -4.13M | |||
| EBITDA (TTM) | -27.88M | |||
| EBIT (TTM) | -35.41M | |||
| Net Income (TTM) | -27.76M | |||
| Net Income Avl. to Common (TTM) | -27.76M | |||
| Total Revenue Growth (Q YOY) | -62.39% | |||
| Earnings Growth (Q YOY) | -28.13% | |||
| EPS Diluted (TTM) | -1.52 | |||
| EPS Diluted Growth (Q YOY) | -16.67% | |||
| Balance Sheet | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 503.00K | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 42.24M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 38.13M | |||
| Current Ratio (Q) | 1.472 | |||
| Book Value Per Share (Q) | $2.00 | |||
| Total Assets (Q) | 91.81M | |||
| Total Current Liabilities (Q) | 28.70M | |||
| Total Debt (Q) | 29.59M | |||
| Total Liabilities (Q) | 53.68M | |||
| Total Common Equity (Q) | 38.13M | |||
| Cash Flow | PRPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.20M | |||
| Cash from Financing (TTM) | 13.37M | |||
| Net Change in Cash (TTM) | 392.00K | |||
| Levered Free Cash Flow (TTM) | -3.54M | |||
| Cash from Operations (TTM) | -14.18M | |||
